Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biosig Technologies (BSGM)

Biosig Technologies (BSGM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 32,033
  • Shares Outstanding, K 17,130
  • Annual Sales, $ 20 K
  • Annual Income, $ -29,040 K
  • EBIT $ -19 M
  • EBITDA $ -18 M
  • 60-Month Beta 0.35
  • Price/Sales 1,855.75
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.20
  • Number of Estimates 1
  • High Estimate -0.20
  • Low Estimate -0.20
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4710 +286.41%
on 10/22/24
2.3300 -21.89%
on 11/12/24
+1.3201 (+264.07%)
since 10/21/24
3-Month
0.2300 +691.30%
on 10/14/24
2.3300 -21.89%
on 11/12/24
+1.3800 (+313.64%)
since 08/21/24
52-Week
0.2010 +805.47%
on 06/12/24
4.9990 -63.59%
on 12/27/23
-1.2830 (-41.35%)
since 11/21/23

Most Recent Stories

More News
BioSig Technologies, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement

BioSig Technologies has regained compliance with Nasdaq's minimum bid price requirement, closing the previous deficiency matter.Quiver AI SummaryBioSig Technologies, Inc. has announced that it has regained...

BSGM : 1.7600 (-5.88%)
BioSig Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

BSGM : 1.7600 (-5.88%)
BioSig Technologies’ Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ Panel

BSGM : 1.7600 (-5.88%)
Global Cardiac Arrhythmia Monitoring Devices Market Size Expected to Reach $11.4 Billion by 2030

Palm Beach, FL – December 14, 2022 – FinancialNewsMedia.com News Commentary – A cardiac arrhythmia is an irregular heartbeat caused by incorrect electrical signals that govern the beats of the heart....

BSGM : 1.7600 (-5.88%)
NMTC : 0.7510 (+3.05%)
RMED : 0.5940 (+10.00%)
IRTC : 73.30 (-0.60%)
MDT : 84.39 (+0.33%)
Global Cardiac Arrhythmia Monitoring Devices Market Size Expected to Reach $11.4 Billion by 2030

/PRNewswire/ -- A cardiac arrhythmia is an irregular heartbeat caused by incorrect electrical signals that govern the beats of the heart. The improper...

BSGM : 1.7600 (-5.88%)
NMTC : 0.7510 (+3.05%)
IRTC : 73.30 (-0.60%)
MDT : 84.39 (+0.33%)
BioSig Announces Physician-Initiated Research Protocol at The Kansas City Heart Rhythm Institute

Led by Dhanunjaya DJ Lakkireddy, MD., the study will investigate expanded applications for the signals acquired by BioSig’s PURE EP(T.M.) System...

BSGM : 1.7600 (-5.88%)
BioSig Announces Purchase Agreement with Kansas City Heart Rhythm Institute at Overland Park Regional Medical Center

Westport, CT, July 07, 2022 (GLOBE NEWSWIRE) -- OPRMC marks our first leasing agreement under new program Company also inks national master agreement...

BSGM : 1.7600 (-5.88%)
BioSig Announces Closing of Public Offering of Common Stock

Westport, CT, June 29, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company...

BSGM : 1.7600 (-5.88%)
BioSig Announces Pricing of Public Offering of Common Stock

Westport, CT, June 24, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company...

BSGM : 1.7600 (-5.88%)
BioSig Announces Proposed Public Offering of Common Stock

Westport, CT, June 23, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company...

BSGM : 1.7600 (-5.88%)

Business Summary

BioSig Technologies is a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals. The Company's first product, PURE EP (tm) System, is a computerized system intended...

See More

Key Turning Points

3rd Resistance Point 2.2433
2nd Resistance Point 2.1167
1st Resistance Point 1.9933
Last Price 1.7600
1st Support Level 1.7433
2nd Support Level 1.6167
3rd Support Level 1.4933

See More

52-Week High 4.9990
Fibonacci 61.8% 3.1662
Fibonacci 50% 2.6000
Fibonacci 38.2% 2.0338
Last Price 1.7600
52-Week Low 0.2010

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar